Drugs for Unmet Needs May Get Faster Approval Under Senate Plan – Bloomberg

November 16, 2011 Posted By: Leave a comment
Hagan and the biotech group’s proposals may be wrapped into a renewal of the law that funds the FDA’s reviews, according to the two aides. The agency and the drug industry have agreed to a 6 percent fee increase as part of a plan that would ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>